CN Stock MarketDetailed Quotes

Zhejiang Garden Biopharmaceutical (300401)

Watchlist
  • 16.39
  • -0.13-0.79%
Trading Jan 16 10:00 CST
8.91BMarket Cap29.53P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Garden Biopharmaceutical (300401) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Vitamin product301.24M47.41%
Drugs192.02M30.22%
Lanolin and its derivatives133.01M20.93%
Other9.1M1.43%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
维生素分部442.68M69.67%
Medicine Division192.68M30.33%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Domestic338.29M53.24%
Abroad297.07M46.76%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +21.49%
Sample Name
Sample Code
 +14.32%
Sample Name
Sample Code
 +14.13%
4
JD HEALTH
06618
+6.19%
5
BIDU-SW
09888
+6.11%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -